Paydirt
RT
Insider

Rahsaan Thompson

Chief Legal & Compliance

Rahsaan Thompson (Chief Legal & Compliance) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Zevra Therapeutics, Inc. (ZVRA). The largest single filing was $475K of ZVRA (42,666 sh × $11.13, as filed), executed Aug 14.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$913K
shares × price, as filed
Last traded
Aug 14
Filed Aug 17

Median ADV $19.3M across their filed names

Open performance
Volume by month
$475K$237K$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2025 · sells $221KJun 2026 · sells $438KAug 2026 · sells $475K
Buys $0 Sells $1.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
ZVRA Zevra Therapeutics, Inc. ZVRA · 0 buys · 3 sells 3 filings
Recent filings
ZVRASALE Zevra Therapeutics, Inc. View filing → $475K
42,666 sh × $11.13
Exec Aug 14
Filed Aug 17 · 4:32 PM ET
ZVRASALE Zevra Therapeutics, Inc. View filing → $438K
34,557 sh × $12.68
Exec Jun 22
Filed Jun 23 · 5:30 PM ET
ZVRASALE Zevra Therapeutics, Inc. View filing → $221K
24,000 sh × $9.21
Exec Jun 26 2025
Filed Jun 30 2025 · 5:30 PM ET